| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 9.03e-05 | 37 | 128 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | MAP kinase activity | 1.36e-04 | 16 | 128 | 3 | GO:0004707 | |
| GeneOntologyMolecularFunction | MAP kinase kinase activity | 1.96e-04 | 18 | 128 | 3 | GO:0004708 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.13e-04 | 46 | 128 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 2.32e-04 | 47 | 128 | 4 | GO:0004712 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.46e-04 | 136 | 128 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8B4 DDX31 KIF27 ERCC6L LRRK2 GFM2 KIF2B MTIF2 ATAD2B HELZ2 ASCC3 MTREX RAB32 DNAH11 | 4.54e-04 | 775 | 128 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 4.72e-04 | 24 | 128 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8B4 DDX31 KIF27 ERCC6L KIF2B ATAD2B HELZ2 ASCC3 MTREX DNAH11 | 5.57e-04 | 441 | 128 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8B4 DDX31 KIF27 ERCC6L HSPA4L ACSL4 KIF2B ATAD2B HELZ2 ASCC3 MTREX DNAH11 | 5.94e-04 | 614 | 128 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DDX31 ERCC6L POLH CDKAL1 AGO3 POP1 HELZ2 EXO1 DBR1 ASCC3 MTREX CNOT1 | 9.12e-04 | 645 | 128 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8B4 DDX31 KIF27 ERCC6L LRRK2 GFM2 KIF2B MTIF2 ATAD2B HELZ2 ASCC3 MTREX RAB32 DNAH11 | 9.85e-04 | 839 | 128 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8B4 DDX31 KIF27 ERCC6L LRRK2 GFM2 KIF2B MTIF2 ATAD2B HELZ2 ASCC3 MTREX RAB32 DNAH11 | 9.97e-04 | 840 | 128 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8B4 DDX31 KIF27 ERCC6L LRRK2 GFM2 KIF2B MTIF2 ATAD2B HELZ2 ASCC3 MTREX RAB32 DNAH11 | 9.97e-04 | 840 | 128 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.48e-03 | 417 | 128 | 9 | GO:0140098 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.67e-03 | 79 | 128 | 4 | GO:0004521 | |
| GeneOntologyBiologicalProcess | organelle disassembly | 4.92e-06 | 204 | 127 | 9 | GO:1903008 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | VPS13C SH3GL1 TRIP4 GFM2 NEDD9 KIF2B MTIF2 ATAD2B SVIL MARK2 PLG ASCC3 KLC1 HTT | 2.74e-05 | 617 | 127 | 14 | GO:0022411 |
| GeneOntologyBiologicalProcess | microtubule-based transport | 2.75e-05 | 253 | 127 | 9 | GO:0099111 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | CCP110 SHOC2 ZNF804A ASAP1 NEDD9 KIDINS220 MARK2 CXCL6 MAP2K1 MAP2K2 CDH4 HTT | 5.54e-05 | 494 | 127 | 12 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | CCP110 LRRK2 TTC3 SHOC2 ZNF804A ASAP1 NEDD9 SLC39A12 KIDINS220 SYNE2 MARK2 CXCL6 MAP2K1 MAP2K2 CDH4 HTT | 6.44e-05 | 846 | 127 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | CCP110 LRRK2 TTC3 SHOC2 ZNF804A ASAP1 NEDD9 SLC39A12 KIDINS220 SYNE2 MARK2 CXCL6 MAP2K1 MAP2K2 CDH4 HTT | 8.14e-05 | 863 | 127 | 16 | GO:0031344 |
| GeneOntologyCellularComponent | focal adhesion | RPL30 TRIM15 EPB41L5 ITGB3 NEDD9 FAT1 PTPRC SVIL SYNE2 MAP2K1 MAP2K2 | 7.58e-05 | 431 | 129 | 11 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | RPL30 TRIM15 EPB41L5 ITGB3 NEDD9 FAT1 PTPRC SVIL SYNE2 MAP2K1 MAP2K2 | 9.66e-05 | 443 | 129 | 11 | GO:0030055 |
| GeneOntologyCellularComponent | activating signal cointegrator 1 complex | 1.13e-04 | 3 | 129 | 2 | GO:0099053 | |
| GeneOntologyCellularComponent | kinesin complex | 2.37e-04 | 49 | 129 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | TRAMP complex | 3.73e-04 | 5 | 129 | 2 | GO:0031499 | |
| Domain | MAPK_p38 | 1.28e-06 | 4 | 129 | 3 | IPR008352 | |
| Domain | MAPK | 6.77e-05 | 12 | 129 | 3 | PS01351 | |
| Domain | MAP_kinase_CS | 6.77e-05 | 12 | 129 | 3 | IPR003527 | |
| Domain | TPR-contain_dom | 8.26e-05 | 150 | 129 | 7 | IPR013026 | |
| Domain | - | 9.63e-05 | 207 | 129 | 8 | 1.25.40.10 | |
| Domain | ARM-type_fold | 1.24e-04 | 339 | 129 | 10 | IPR016024 | |
| Domain | KINESIN_LIGHT | 1.41e-04 | 3 | 129 | 2 | PS01160 | |
| Domain | Kinesin_light_repeat | 1.41e-04 | 3 | 129 | 2 | IPR015792 | |
| Domain | TPR_REGION | 1.50e-04 | 165 | 129 | 7 | PS50293 | |
| Domain | TPR | 1.50e-04 | 165 | 129 | 7 | PS50005 | |
| Domain | TPR-like_helical_dom | 2.17e-04 | 233 | 129 | 8 | IPR011990 | |
| Domain | P-loop_NTPase | MPP3 DDX31 KIF27 ERCC6L LRRK2 CMPK2 GFM2 KIF2B MTIF2 ATAD2B HELZ2 AK2 ASCC3 MTREX RAB32 DNAH11 | 2.48e-04 | 848 | 129 | 16 | IPR027417 |
| Domain | TPR | 2.75e-04 | 129 | 129 | 6 | SM00028 | |
| Domain | Kinesin_light | 2.81e-04 | 4 | 129 | 2 | IPR002151 | |
| Domain | TPR_repeat | 3.24e-04 | 133 | 129 | 6 | IPR019734 | |
| Domain | MAPK_JNK | 4.67e-04 | 5 | 129 | 2 | IPR008351 | |
| Domain | Pentatricopeptide_repeat | 5.15e-04 | 23 | 129 | 3 | IPR002885 | |
| Domain | - | MPP3 DDX31 ERCC6L LRRK2 CMPK2 GFM2 MTIF2 ATAD2B HELZ2 AK2 ASCC3 MTREX RAB32 DNAH11 | 6.50e-04 | 746 | 129 | 14 | 3.40.50.300 |
| Domain | Rab5-bind | 6.97e-04 | 6 | 129 | 2 | PF09311 | |
| Domain | Rabaptin_Rab5-bd_dom | 6.97e-04 | 6 | 129 | 2 | IPR015390 | |
| Domain | TPR_10 | 6.97e-04 | 6 | 129 | 2 | PF13374 | |
| Domain | ZnF_UBR1 | 9.72e-04 | 7 | 129 | 2 | SM00396 | |
| Domain | ZF_UBR | 9.72e-04 | 7 | 129 | 2 | PS51157 | |
| Domain | zf-UBR | 9.72e-04 | 7 | 129 | 2 | PF02207 | |
| Domain | Znf_UBR | 9.72e-04 | 7 | 129 | 2 | IPR003126 | |
| Domain | LRR_8 | 1.21e-03 | 171 | 129 | 6 | PF13855 | |
| Domain | LRR_TYP | 1.45e-03 | 177 | 129 | 6 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.45e-03 | 177 | 129 | 6 | IPR003591 | |
| Domain | Ubiquitin-rel_dom | 1.76e-03 | 184 | 129 | 6 | IPR029071 | |
| Domain | PTX | 2.05e-03 | 10 | 129 | 2 | SM00159 | |
| Domain | Ephrin_rec_like | 2.50e-03 | 11 | 129 | 2 | PF07699 | |
| Domain | Pentaxin-related | 2.50e-03 | 11 | 129 | 2 | IPR001759 | |
| Domain | Pentaxin | 2.50e-03 | 11 | 129 | 2 | PF00354 | |
| Domain | ARM-like | 2.73e-03 | 270 | 129 | 7 | IPR011989 | |
| Domain | LRR | 2.74e-03 | 201 | 129 | 6 | PS51450 | |
| Domain | Ser/Thr_kinase_AS | 3.39e-03 | 357 | 129 | 8 | IPR008271 | |
| Domain | S_TKc | 3.50e-03 | 359 | 129 | 8 | SM00220 | |
| Domain | TPR_1 | 3.51e-03 | 90 | 129 | 4 | IPR001440 | |
| Domain | TPR_1 | 3.51e-03 | 90 | 129 | 4 | PF00515 | |
| Domain | PROTEIN_KINASE_ST | 3.68e-03 | 362 | 129 | 8 | PS00108 | |
| Domain | Gelsolin | 4.08e-03 | 14 | 129 | 2 | PF00626 | |
| Domain | Gelsolin-like_dom | 4.08e-03 | 14 | 129 | 2 | IPR007123 | |
| Domain | MS4A | 4.08e-03 | 14 | 129 | 2 | IPR030417 | |
| Domain | ZF_RING_1 | 4.12e-03 | 291 | 129 | 7 | PS00518 | |
| Domain | LRR_1 | 4.18e-03 | 219 | 129 | 6 | PF00560 | |
| Domain | - | 4.46e-03 | 222 | 129 | 6 | 1.25.10.10 | |
| Domain | ZF_RING_2 | 4.69e-03 | 298 | 129 | 7 | PS50089 | |
| Domain | Protein_kinase_ATP_BS | 4.84e-03 | 379 | 129 | 8 | IPR017441 | |
| Domain | TPR_2 | 4.98e-03 | 50 | 129 | 3 | PF07719 | |
| Domain | TPR_2 | 4.98e-03 | 50 | 129 | 3 | IPR013105 | |
| Domain | Pkinase | 5.00e-03 | 381 | 129 | 8 | PF00069 | |
| Domain | Helicase_C | 6.48e-03 | 107 | 129 | 4 | PF00271 | |
| Domain | HELICc | 6.48e-03 | 107 | 129 | 4 | SM00490 | |
| Domain | Helicase_C | 6.70e-03 | 108 | 129 | 4 | IPR001650 | |
| Domain | EFTu-like_2 | 6.74e-03 | 18 | 129 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 6.74e-03 | 18 | 129 | 2 | PF03144 | |
| Domain | G_TR_2 | 6.74e-03 | 18 | 129 | 2 | PS51722 | |
| Domain | Znf_C3HC4_RING-type | 6.88e-03 | 172 | 129 | 5 | IPR018957 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 9.82e-08 | 34 | 96 | 6 | M13881 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 7.74e-07 | 26 | 96 | 5 | M47565 | |
| Pathway | WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION | 9.45e-07 | 27 | 96 | 5 | M39838 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 1.14e-06 | 28 | 96 | 5 | M39572 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 4.21e-06 | 36 | 96 | 5 | M39908 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 6.03e-06 | 6 | 96 | 3 | M47766 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 2.69e-05 | 26 | 96 | 4 | MM14716 | |
| Pathway | WP_MAPK_CASCADE | 3.65e-05 | 28 | 96 | 4 | MM15976 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 4.21e-05 | 29 | 96 | 4 | M39676 | |
| Pathway | WP_MAPK_CASCADE | 7.10e-05 | 33 | 96 | 4 | M39594 | |
| Pathway | SIG_CD40PATHWAYMAP | 8.01e-05 | 34 | 96 | 4 | M12705 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 8.33e-05 | 13 | 96 | 3 | M1441 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 9.32e-05 | 108 | 96 | 6 | M9904 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 1.05e-04 | 69 | 96 | 5 | M237 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 1.06e-04 | 14 | 96 | 3 | M622 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 1.06e-04 | 14 | 96 | 3 | MM14667 | |
| Pathway | WP_INSULIN_SIGNALING | 1.09e-04 | 160 | 96 | 7 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 1.09e-04 | 160 | 96 | 7 | M39482 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | SH3GL1 GRB10 RICTOR ITGB3 MAPK14 KIDINS220 MAPK12 PLG MAPK13 MAP2K1 MAP2K2 | 1.25e-04 | 418 | 96 | 11 | MM15587 |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 1.38e-04 | 39 | 96 | 4 | MM15272 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 1.53e-04 | 40 | 96 | 4 | M27557 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.66e-04 | 76 | 96 | 5 | MM1433 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 1.66e-04 | 76 | 96 | 5 | M1749 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 1.88e-04 | 78 | 96 | 5 | M39824 | |
| Pathway | WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE | 1.94e-04 | 17 | 96 | 3 | M39564 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 1.94e-04 | 17 | 96 | 3 | M8353 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 1.94e-04 | 17 | 96 | 3 | MM1408 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 2.00e-04 | 79 | 96 | 5 | M11816 | |
| Pathway | PID_CXCR3_PATHWAY | 2.03e-04 | 43 | 96 | 4 | M222 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 2.18e-04 | 126 | 96 | 6 | M16763 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.25e-04 | 81 | 96 | 5 | M13863 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.74e-04 | 19 | 96 | 3 | MM15113 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 2.80e-04 | 132 | 96 | 6 | M39338 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 2.94e-04 | 188 | 96 | 7 | MM15828 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 3.03e-04 | 134 | 96 | 6 | M3574 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 3.21e-04 | 20 | 96 | 3 | M12256 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 3.72e-04 | 21 | 96 | 3 | M878 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING | 3.95e-04 | 51 | 96 | 4 | M39438 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS | 4.29e-04 | 22 | 96 | 3 | M39902 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 4.53e-04 | 5 | 96 | 2 | M49016 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING | 4.91e-04 | 23 | 96 | 3 | M39709 | |
| Pathway | WP_LDL_INFLUENCE_ON_CD14_AND_TLR4 | 4.91e-04 | 23 | 96 | 3 | M45556 | |
| Pathway | REACTOME_MYOGENESIS | 5.58e-04 | 24 | 96 | 3 | MM15174 | |
| Pathway | REACTOME_KINESINS | 6.05e-04 | 57 | 96 | 4 | MM15714 | |
| Pathway | WP_PARKINSONS_DISEASE | 6.05e-04 | 57 | 96 | 4 | MM15899 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 6.24e-04 | 101 | 96 | 5 | M1979 | |
| Pathway | WP_THYROXINE_THYROID_HORMONE_PRODUCTION | 6.31e-04 | 25 | 96 | 3 | M39353 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 6.52e-04 | 102 | 96 | 5 | M3261 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 6.76e-04 | 6 | 96 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 6.76e-04 | 6 | 96 | 2 | MM15273 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 6.76e-04 | 6 | 96 | 2 | M47636 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 6.82e-04 | 103 | 96 | 5 | M39434 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 6.82e-04 | 103 | 96 | 5 | MM14752 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 6.90e-04 | 59 | 96 | 4 | M39350 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | GRB10 RICTOR ITGB3 TRIP4 MAPK14 MAPK12 STIP1 ASCC3 MAP2K1 MAP2K2 | 6.94e-04 | 431 | 96 | 10 | M39729 |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 7.10e-04 | 26 | 96 | 3 | M39687 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 7.10e-04 | 26 | 96 | 3 | MM1431 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.10e-04 | 26 | 96 | 3 | M47672 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 7.10e-04 | 26 | 96 | 3 | MM15896 | |
| Pathway | WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY | 7.36e-04 | 60 | 96 | 4 | M39583 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 7.77e-04 | 106 | 96 | 5 | M27077 | |
| Pathway | REACTOME_KINESINS | 7.83e-04 | 61 | 96 | 4 | M977 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 7.95e-04 | 27 | 96 | 3 | M7739 | |
| Pathway | WP_EGFEGFR_SIGNALING | 8.30e-04 | 162 | 96 | 6 | M39334 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 8.85e-04 | 63 | 96 | 4 | MM14714 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | SH3GL1 GRB10 RICTOR ITGB3 MAPK14 KIDINS220 MAPK12 PLG MAPK13 MAP2K1 MAP2K2 | 9.66e-04 | 532 | 96 | 11 | M27870 |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 9.84e-04 | 29 | 96 | 3 | MM1356 | |
| Pathway | REACTOME_MYOGENESIS | 9.84e-04 | 29 | 96 | 3 | M853 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 9.84e-04 | 29 | 96 | 3 | M13494 | |
| Pathway | WP_ONCOSTATIN_M_SIGNALING | 9.95e-04 | 65 | 96 | 4 | M39562 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.38e-03 | 71 | 96 | 4 | M15913 | |
| Pathway | WP_PARKINSONS_DISEASE_PATHWAY | 1.38e-03 | 71 | 96 | 4 | M39461 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 1.44e-03 | 33 | 96 | 3 | M47550 | |
| Pathway | REACTOME_NOD1_2_SIGNALING_PATHWAY | 1.44e-03 | 33 | 96 | 3 | MM14663 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 CCP110 ERCC6L KLC2 PTPN13 MAPK14 KIDINS220 KIF2B SYDE2 STIP1 KLC1 ARAP2 | 1.48e-03 | 649 | 96 | 12 | MM15690 |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.57e-03 | 34 | 96 | 3 | M10287 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.57e-03 | 34 | 96 | 3 | M27556 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.57e-03 | 34 | 96 | 3 | MM1399 | |
| Pathway | WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1 | 1.60e-03 | 9 | 96 | 2 | M39481 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.60e-03 | 9 | 96 | 2 | M47699 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.70e-03 | 75 | 96 | 4 | M39568 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.70e-03 | 75 | 96 | 4 | MM14652 | |
| Pathway | KEGG_PRION_DISEASES | 1.71e-03 | 35 | 96 | 3 | M13036 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.71e-03 | 35 | 96 | 3 | MM15271 | |
| Pathway | REACTOME_NOD1_2_SIGNALING_PATHWAY | 1.86e-03 | 36 | 96 | 3 | M1059 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY | 1.99e-03 | 10 | 96 | 2 | M47374 | |
| Pathway | REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION | 1.99e-03 | 10 | 96 | 2 | M27146 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 1.99e-03 | 10 | 96 | 2 | M47420 | |
| Pathway | WP_ETHANOL_METABOLISM_RESULTING_IN_PRODUCTION_OF_ROS_BY_CYP2E1 | 1.99e-03 | 10 | 96 | 2 | MM15821 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY | 1.99e-03 | 10 | 96 | 2 | M47735 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 2.01e-03 | 37 | 96 | 3 | M42558 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 2.35e-03 | 82 | 96 | 4 | M27626 | |
| Pathway | PID_P38_GAMMA_DELTA_PATHWAY | 2.43e-03 | 11 | 96 | 2 | M209 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 2.43e-03 | 11 | 96 | 2 | M18837 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.43e-03 | 11 | 96 | 2 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.43e-03 | 11 | 96 | 2 | M47371 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS | 2.43e-03 | 11 | 96 | 2 | M27420 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 2.43e-03 | 11 | 96 | 2 | MM1432 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_KTN1 | 2.43e-03 | 11 | 96 | 2 | M27490 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_KTN1 | 2.43e-03 | 11 | 96 | 2 | MM15218 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 ERCC6L ZCCHC8 SH3GL1 KLC2 EPB41L5 GRB10 RICTOR PTPN13 MTUS1 SYDE2 SVIL SYNE2 SEC24B EXO1 MARK2 MTREX MAP2K1 MAP2K2 KLC1 ARAP2 DYRK2 | 1.05e-12 | 861 | 129 | 22 | 36931259 |
| Pubmed | RPL30 DDX31 HSPA4L UBR4 BAG1 EPB41L5 SMPD4 RICTOR UBE2M SPG11 TTC3 TRIP4 CDKAL1 PTPN13 KIDINS220 STXBP3 MTIF2 SYNE2 POP1 PRKAR2B ANKRD28 STIP1 ATXN10 MARK2 ASCC3 MAP2K1 KLC1 | 6.11e-12 | 1487 | 129 | 27 | 33957083 | |
| Pubmed | DDX31 SMPD4 RICTOR SHOC2 ASAP1 ACSL4 PTPN13 MAPK14 PTPRC STXBP3 MTUS1 SVIL SYNE2 SEC24B ANKRD28 AK2 STIP1 ATXN10 CNOT1 | 1.23e-08 | 1049 | 129 | 19 | 27880917 | |
| Pubmed | Nerve growth factor signaling, neuroprotection, and neural repair. | 4.01e-08 | 26 | 129 | 5 | 11520933 | |
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 18559936 | ||
| Pubmed | RGPD4 ZCCHC8 POLH UBR4 USP24 MECOM PTPN13 SEC23IP ANKRD28 ASCC3 CNOT1 KLC1 | 5.73e-08 | 418 | 129 | 12 | 34709266 | |
| Pubmed | SH3GL1 EPB41L5 SMPD4 CDKAL1 PTPN13 KIDINS220 SVIL SEC24B SEC23IP CNOT1 | 5.76e-08 | 263 | 129 | 10 | 34702444 | |
| Pubmed | ERCC6L HSPA4L USP24 EPB41L5 RICTOR UBE2M CDKAL1 PTPN13 KIDINS220 SEC24B SEC23IP STIP1 MARK2 ASCC3 CNOT1 | 6.47e-08 | 708 | 129 | 15 | 39231216 | |
| Pubmed | CCP110 ZCCHC8 KLC2 RICTOR PTPN13 EXO1 ANKRD28 MARK2 MTREX MAP2K1 MAP2K2 CNOT1 | 1.15e-07 | 446 | 129 | 12 | 24255178 | |
| Pubmed | RPL30 DDX31 ZCCHC8 UBR4 USP24 CUL9 ATAD2B SYNE2 POP1 HELZ2 ANKRD28 ASCC3 MTREX CNOT1 | 1.58e-07 | 653 | 129 | 14 | 22586326 | |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 20610565 | ||
| Pubmed | Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis. | 1.99e-07 | 4 | 129 | 3 | 18177852 | |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 10066767 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 22298595 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 15632108 | ||
| Pubmed | MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation. | 4.96e-07 | 5 | 129 | 3 | 35971771 | |
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 20710027 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 17304211 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 27098723 | ||
| Pubmed | RGPD4 UBR4 TTC3 FRY AGO3 SVIL SYNE2 SEC23IP DZIP3 PRKAR2B ANKRD28 STIP1 UNC79 CNOT1 UNC13A KLC1 | 6.06e-07 | 963 | 129 | 16 | 28671696 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPL30 HSPA4L ZCCHC8 VPS13C UBR4 SMPD4 TTC3 GFM2 CDKAL1 ACSL4 MTIF2 MTFR1 SYNE2 SEC24B SEC23IP PRKAR2B AK2 STIP1 ATXN10 MARK2 | 6.68e-07 | 1496 | 129 | 20 | 32877691 |
| Pubmed | Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice. | 9.89e-07 | 6 | 129 | 3 | 27856911 | |
| Pubmed | 9.89e-07 | 6 | 129 | 3 | 14680475 | ||
| Pubmed | 1.17e-06 | 282 | 129 | 9 | 23667531 | ||
| Pubmed | VPS13C SH3GL1 SMPD4 UBE2M CDKAL1 MTFR1 SYNE2 SEC24B SEC23IP STIP1 PRR14L KLC1 | 1.48e-06 | 568 | 129 | 12 | 37774976 | |
| Pubmed | 1.62e-06 | 53 | 129 | 5 | 16964442 | ||
| Pubmed | Systematic discovery of nonobvious human disease models through orthologous phenotypes. | 1.73e-06 | 7 | 129 | 3 | 20308572 | |
| Pubmed | Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. | 2.75e-06 | 8 | 129 | 3 | 9155017 | |
| Pubmed | 3.43e-06 | 169 | 129 | 7 | 31462741 | ||
| Pubmed | CCP110 ERCC6L VPS13C EPB41L5 MECOM SMPD4 SPG11 TRIP4 CDKAL1 STXBP3 SEC23IP ANKRD28 PRR14L | 3.65e-06 | 733 | 129 | 13 | 34672954 | |
| Pubmed | UBR1 RPL30 HSPA4L SH3GL1 KLC2 TRIP4 SVIL SEC24B POP1 ANKRD28 STIP1 MARK2 ASCC3 MTREX MAP2K1 MAP2K2 KLC1 | 3.87e-06 | 1247 | 129 | 17 | 27684187 | |
| Pubmed | 4.12e-06 | 9 | 129 | 3 | 23555914 | ||
| Pubmed | Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis. | 4.12e-06 | 9 | 129 | 3 | 16887817 | |
| Pubmed | PLVAP ERCC6L ORC3 UBR4 USP24 ACSL4 SYNE2 SEC23IP IL17RD MAP2K2 CNOT1 DNAH11 | 4.87e-06 | 638 | 129 | 12 | 31182584 | |
| Pubmed | ERCC6L USP24 EPB41L5 SHOC2 FAT1 KIDINS220 SEC23IP ANKRD28 ATXN10 MAP2K2 CNOT1 | 5.17e-06 | 533 | 129 | 11 | 25544563 | |
| Pubmed | Grhl3 and Lmo4 play coordinate roles in epidermal migration. | 5.87e-06 | 10 | 129 | 3 | 18619436 | |
| Pubmed | 5.87e-06 | 10 | 129 | 3 | 18952847 | ||
| Pubmed | UBR1 RPL30 ERCC6L ORC3 RICTOR ITGB3 MTIF2 POP1 ANKRD28 DBR1 MARK2 MTREX | 5.88e-06 | 650 | 129 | 12 | 38777146 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 ERCC6L ZCCHC8 USP24 KLC2 RICTOR PTPRC SVIL POP1 HELZ2 EXO1 MARK2 MAP2K2 | 6.55e-06 | 774 | 129 | 13 | 15302935 |
| Pubmed | ERCC6L SH3GL1 USP24 UBE2M PTPN13 SEC24B SEC23IP ASCC3 CNOT1 KLC1 HTT | 6.82e-06 | 549 | 129 | 11 | 38280479 | |
| Pubmed | VPS13C LRRK2 EPB41L5 RICTOR FAT1 PTPN13 KIDINS220 SYDE2 MTFR1 SEC24B SEC23IP ANKRD28 ARAP2 | 6.83e-06 | 777 | 129 | 13 | 35844135 | |
| Pubmed | RPL30 ERCC6L UBR4 KLC2 CDKAL1 ACSL4 SLC44A1 KIDINS220 PTPRC AGO3 HELZ2 ATXN10 ASCC3 MCTP2 CNOT1 KLC1 | 7.18e-06 | 1168 | 129 | 16 | 19946888 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CCP110 LRRC57 ERCC6L ZCCHC8 GRB10 RICTOR TRIP4 STXBP3 AGO3 SEC24B SEC23IP DBR1 MTREX MAP2K2 CNOT1 | 7.55e-06 | 1038 | 129 | 15 | 26673895 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | LRRC57 ERCC6L EPB41L5 SMPD4 RICTOR FAT1 KIDINS220 STXBP3 MARK2 MAPK13 ARAP2 | 9.54e-06 | 569 | 129 | 11 | 30639242 |
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 1.07e-05 | 12 | 129 | 3 | 9297626 | |
| Pubmed | 1.07e-05 | 12 | 129 | 3 | 12171600 | ||
| Pubmed | 1.10e-05 | 202 | 129 | 7 | 24639526 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | KIF27 ERCC6L ORC3 USP24 UBE2M SHOC2 THAP1 MARK2 MTREX MAP2K2 CNOT1 | 1.18e-05 | 582 | 129 | 11 | 20467437 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.19e-05 | 475 | 129 | 10 | 31040226 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | LRRC57 KLC2 EPB41L5 RICTOR ITGB3 PTPN13 KIDINS220 STXBP3 MARK2 | 1.23e-05 | 377 | 129 | 9 | 38117590 |
| Pubmed | Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. | 1.37e-05 | 2 | 129 | 2 | 9563949 | |
| Pubmed | p38γ and p38δ modulate innate immune response by regulating MEF2D activation. | 1.37e-05 | 2 | 129 | 2 | 37458356 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12832465 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19014680 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 10727080 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 26625317 | ||
| Pubmed | BAG-1 associates with the polyglutamine-expanded huntingtin aggregates. | 1.37e-05 | 2 | 129 | 2 | 15781153 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 20804750 | ||
| Pubmed | PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. | 1.37e-05 | 2 | 129 | 2 | 15155804 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 25217523 | ||
| Pubmed | p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. | 1.37e-05 | 2 | 129 | 2 | 19251701 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21699731 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17419998 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 35599981 | ||
| Pubmed | Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. | 1.37e-05 | 2 | 129 | 2 | 9295308 | |
| Pubmed | MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response. | 1.37e-05 | 2 | 129 | 2 | 23735655 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19539422 | ||
| Pubmed | The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma. | 1.37e-05 | 2 | 129 | 2 | 35069558 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22470497 | ||
| Pubmed | p38α blocks brown adipose tissue thermogenesis through p38δ inhibition. | 1.37e-05 | 2 | 129 | 2 | 29979672 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21527500 | ||
| Pubmed | Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia. | 1.37e-05 | 2 | 129 | 2 | 19383924 | |
| Pubmed | Active mutants of the human p38alpha mitogen-activated protein kinase. | 1.37e-05 | 2 | 129 | 2 | 15284239 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15284233 | ||
| Pubmed | Alternative p38 MAPKs are essential for collagen-induced arthritis. | 1.37e-05 | 2 | 129 | 2 | 24782184 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19156172 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12839928 | ||
| Pubmed | MEK1/2 inhibition promotes Taxotere lethality in mammary tumors in vivo. | 1.37e-05 | 2 | 129 | 2 | 16957420 | |
| Pubmed | A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. | 1.37e-05 | 2 | 129 | 2 | 7914033 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19144315 | ||
| Pubmed | Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration. | 1.37e-05 | 2 | 129 | 2 | 29460266 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19500021 | ||
| Pubmed | Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. | 1.37e-05 | 2 | 129 | 2 | 22197931 | |
| Pubmed | p38δ genetic ablation protects female mice from anthracycline cardiotoxicity. | 1.37e-05 | 2 | 129 | 2 | 32822209 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 27956260 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17981815 | ||
| Pubmed | Structural plasticity of the N-terminal capping helix of the TPR domain of kinesin light chain. | 1.37e-05 | 2 | 129 | 2 | 29036226 | |
| Pubmed | Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells. | 1.37e-05 | 2 | 129 | 2 | 28746311 | |
| Pubmed | Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis. | 1.37e-05 | 2 | 129 | 2 | 26079427 | |
| Pubmed | Intrinsically active MEK variants are differentially regulated by proteinases and phosphatases. | 1.37e-05 | 2 | 129 | 2 | 30087384 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22833572 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17035228 | ||
| Pubmed | Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice. | 1.37e-05 | 2 | 129 | 2 | 15561967 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 26163823 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15849811 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 36189831 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22805292 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22805291 | ||
| Pubmed | Biphasic regulation of osteoblast development via the ERK MAPK-mTOR pathway. | 1.37e-05 | 2 | 129 | 2 | 35975983 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16162927 | ||
| Interaction | YWHAH interactions | CCP110 ERCC6L ZCCHC8 SH3GL1 LRRK2 BAG1 KLC2 EPB41L5 GRB10 RICTOR UBE2M PTPN13 MTUS1 SYDE2 SVIL SYNE2 SEC24B EXO1 MARK2 MTREX MAP2K1 MAP2K2 KLC1 HTT ARAP2 | 2.02e-08 | 1102 | 127 | 25 | int:YWHAH |
| Interaction | YWHAG interactions | CCP110 ERCC6L SH3GL1 LRRK2 BAG1 USP24 KLC2 EPB41L5 GRB10 RICTOR UBE2M PTPN13 MTUS1 SYDE2 SVIL SYNE2 SEC24B EXO1 STIP1 MARK2 MTREX MAP2K1 MAP2K2 KLC1 HTT ARAP2 | 5.56e-08 | 1248 | 127 | 26 | int:YWHAG |
| Interaction | SFN interactions | CCP110 ERCC6L LONRF1 LRRK2 KLC2 EPB41L5 GRB10 RICTOR IVL PTPN13 ISG15 MTUS1 SVIL EXO1 MARK2 MTREX KLC1 HTT ARAP2 | 6.87e-08 | 692 | 127 | 19 | int:SFN |
| Interaction | HSPA4 interactions | CCP110 HSPA4L LRRK2 BAG1 KLC2 GRB10 RICTOR UBE2M TTC3 ITGB3 ISG15 MTUS1 SEC23IP STIP1 PRR14L MARK2 MAP2K2 HTT | 2.03e-07 | 667 | 127 | 18 | int:HSPA4 |
| Interaction | YWHAQ interactions | CCP110 LRRK2 BAG1 KLC2 EPB41L5 RICTOR UBE2M ACSL4 PTPN13 MTUS1 SYDE2 SVIL EXO1 STIP1 MARK2 PLG MTREX MAP2K1 MAP2K2 UNC79 KLC1 HTT ARAP2 | 4.62e-07 | 1118 | 127 | 23 | int:YWHAQ |
| Interaction | YWHAB interactions | CCP110 ZCCHC8 LRRK2 BAG1 KLC2 EPB41L5 RICTOR UBE2M SHOC2 PTPN13 ISG15 SYDE2 SVIL EXO1 MARK2 MTREX MAP2K1 MAP2K2 KLC1 HTT ARAP2 | 1.41e-06 | 1014 | 127 | 21 | int:YWHAB |
| Interaction | YWHAZ interactions | CCP110 SH3GL1 LRRK2 KLC2 GRB10 RICTOR UBE2M PTPN13 MTUS1 SYDE2 SVIL SYNE2 EXO1 PRKAR2B ANKRD28 STIP1 PRR14L MARK2 MTREX MAP2K1 MAP2K2 KLC1 HTT ARAP2 | 2.22e-06 | 1319 | 127 | 24 | int:YWHAZ |
| Interaction | GOLGA1 interactions | 2.43e-06 | 183 | 127 | 9 | int:GOLGA1 | |
| Interaction | HSP90AA1 interactions | RPL30 POLH UBR4 LRRK2 BAG1 RICTOR UBE2M SPG11 MAPK14 AGO3 ISG15 SYDE2 SVIL STIP1 PRR14L MARK2 PLG MTREX MAPK13 MAP2K1 MAP2K2 HTT DYRK2 | 3.70e-06 | 1263 | 127 | 23 | int:HSP90AA1 |
| Interaction | DNAJB6 interactions | DDX31 SH3GL1 LRRK2 BAG1 MECOM UBE2M ASAP1 ISG15 STIP1 MAP2K1 MAP2K2 HTT | 5.07e-06 | 379 | 127 | 12 | int:DNAJB6 |
| Interaction | RHOA interactions | DDX31 VPS13C LRRK2 EPB41L5 SMPD4 RICTOR CDKAL1 ADGRG6 ACSL4 FAT1 PTPN13 KIDINS220 STXBP3 SYNE2 SEC23IP MARK2 MAP2K1 MAP2K2 RAB32 MCTP2 HTT ARAP2 | 5.51e-06 | 1199 | 127 | 22 | int:RHOA |
| Interaction | HNRNPK interactions | CCP110 RPL30 VPS13C SH3GL1 BAG1 RICTOR UBE2M ACSL4 ISG15 SYNE2 SEC24B ANKRD28 STIP1 MTREX MAP2K1 MAP2K2 KLC1 HTT | 6.74e-06 | 853 | 127 | 18 | int:HNRNPK |
| Interaction | BAG2 interactions | VPS13C LRRK2 KLC2 GRB10 MECOM RICTOR UBE2M SPG11 TRIM66 ISG15 STIP1 PRR14L ASCC3 MAP2K2 HTT | 8.90e-06 | 622 | 127 | 15 | int:BAG2 |
| Interaction | RACK1 interactions | RPL30 BAG1 RICTOR UBE2M TRIP4 NEDD9 MAPK14 ISG15 POP1 AK2 STIP1 ASCC3 MAP2K1 MAP2K2 HTT DYRK2 | 9.20e-06 | 704 | 127 | 16 | int:RACK1 |
| Interaction | HSPB1 interactions | LONRF1 LRRK2 GRB10 MECOM RICTOR TTC3 SHOC2 MAPK14 ISG15 MTIF2 STIP1 ATXN10 PLG MAP2K1 KLC1 HTT | 9.87e-06 | 708 | 127 | 16 | int:HSPB1 |
| Interaction | PHF21A interactions | ZCCHC8 POLH UBR4 USP24 MECOM PTPN13 SEC23IP DZIP3 ANKRD28 ASCC3 KLC1 | 1.13e-05 | 343 | 127 | 11 | int:PHF21A |
| Interaction | YWHAE interactions | LRRK2 KLC2 GRB10 RICTOR UBE2M TTC3 SHOC2 PTPN13 MAPK14 STXBP3 SYDE2 SVIL SEC23IP EXO1 STIP1 MARK2 MTREX MAP2K1 MAP2K2 KLC1 HTT ARAP2 | 1.15e-05 | 1256 | 127 | 22 | int:YWHAE |
| Interaction | VIM interactions | UBR1 CCP110 TRIM15 SH3GL1 UBR4 LRRK2 BAG1 RICTOR UBE2M ITGB3 NEDD9 ISG15 SVIL DZIP3 STIP1 ASCC3 HTT | 1.21e-05 | 804 | 127 | 17 | int:VIM |
| Interaction | RNF43 interactions | HSPA4L SH3GL1 EPB41L5 SMPD4 CDKAL1 PTPN13 KIDINS220 SVIL SEC24B SEC23IP STIP1 CNOT1 | 1.68e-05 | 427 | 127 | 12 | int:RNF43 |
| Interaction | PLEC interactions | LRRK2 MECOM RICTOR ITGB3 ADH6 ISG15 SYDE2 SYNE2 SEC24B EXO1 STIP1 HTT | 1.80e-05 | 430 | 127 | 12 | int:PLEC |
| Interaction | RHOC interactions | EPB41L5 SMPD4 RICTOR CDKAL1 ADGRG6 FAT1 PTPN13 KIDINS220 STXBP3 SYNE2 MARK2 RAB32 MCTP2 HTT | 1.93e-05 | 584 | 127 | 14 | int:RHOC |
| Interaction | IQGAP1 interactions | LRRK2 MECOM RICTOR UBE2M ITGB3 TRIP4 MAPK14 ISG15 SVIL STIP1 ASCC3 MAP2K1 MAP2K2 KLC1 | 2.20e-05 | 591 | 127 | 14 | int:IQGAP1 |
| Interaction | RAC2 interactions | EPB41L5 SMPD4 RICTOR CDKAL1 ADGRG6 FAT1 ELMO3 KIDINS220 STXBP3 SYNE2 SEC23IP MARK2 RAB32 MCTP2 HTT | 2.28e-05 | 674 | 127 | 15 | int:RAC2 |
| Interaction | KCNA3 interactions | ERCC6L HSPA4L LRRK2 USP24 EPB41L5 GRB10 RICTOR UBE2M CDKAL1 PTPN13 KIDINS220 SEC24B SEC23IP STIP1 MARK2 ASCC3 CNOT1 | 3.36e-05 | 871 | 127 | 17 | int:KCNA3 |
| Interaction | RAC1 interactions | DDX31 LRRK2 EPB41L5 RICTOR UBE2M ASAP1 ADGRG6 FAT1 PTPN13 KIDINS220 STXBP3 AGO3 SYDE2 MARK2 MAP2K1 MAP2K2 RAB32 HTT ARAP2 | 3.73e-05 | 1063 | 127 | 19 | int:RAC1 |
| Interaction | CALM1 interactions | CCP110 VPS13C SH3GL1 UBR4 LRRK2 BAG1 UBE2M GFM2 MAPK14 SCN2A SVIL SYNE2 PRKAR2B HTT | 4.13e-05 | 626 | 127 | 14 | int:CALM1 |
| Interaction | SNCA interactions | HSPA4L ZCCHC8 VPS13C UBR4 LRRK2 USP24 KLC2 EPB41L5 STXBP3 SVIL SYNE2 PRKAR2B STIP1 MTREX KLC1 | 4.57e-05 | 716 | 127 | 15 | int:SNCA |
| Interaction | EZR interactions | MPP3 HSPA4L BAG1 EPB41L5 RICTOR ASAP1 KIDINS220 PTPRC ISG15 SVIL ANKRD28 STIP1 MARK2 | 4.76e-05 | 553 | 127 | 13 | int:EZR |
| Interaction | GRPEL1 interactions | 5.64e-05 | 210 | 127 | 8 | int:GRPEL1 | |
| Interaction | RHOD interactions | DDX31 EPB41L5 SMPD4 RICTOR CDKAL1 PTPN13 KIDINS220 STXBP3 SYNE2 MARK2 MAP2K1 MAP2K2 RAB32 | 6.70e-05 | 572 | 127 | 13 | int:RHOD |
| Interaction | CLTC interactions | LRRK2 BAG1 KLC2 MECOM RICTOR UBE2M ITGB3 KIDINS220 ISG15 MTUS1 SVIL SEC24B STIP1 MAP2K1 | 6.72e-05 | 655 | 127 | 14 | int:CLTC |
| Interaction | SIRT7 interactions | RPL30 DDX31 ZCCHC8 POLH UBR4 USP24 CUL9 ATAD2B SYNE2 POP1 HELZ2 ANKRD28 ASCC3 MTREX CNOT1 | 7.04e-05 | 744 | 127 | 15 | int:SIRT7 |
| Interaction | SPTAN1 interactions | KLC2 UBE2M TTC3 ITGB3 AGO3 ISG15 SVIL SYNE2 DZIP3 STIP1 DBR1 HTT | 7.18e-05 | 496 | 127 | 12 | int:SPTAN1 |
| Interaction | GJA1 interactions | EPB41L5 SMPD4 RICTOR CDKAL1 SLC39A12 PTPN13 KIDINS220 SYNE2 SEC24B SEC23IP MARK2 HTT ARAP2 | 8.12e-05 | 583 | 127 | 13 | int:GJA1 |
| Interaction | HERC2 interactions | CCP110 RPL30 UBR4 LRRK2 TTC3 KIF2B SYNE2 SEC23IP PRKAR2B PRR14L MARK2 CNOT1 | 8.20e-05 | 503 | 127 | 12 | int:HERC2 |
| Interaction | RHOF interactions | DDX31 EPB41L5 RICTOR FAT1 PTPN13 KIDINS220 STXBP3 STIP1 ATXN10 MARK2 MAP2K1 MAP2K2 RAB32 HTT | 8.96e-05 | 673 | 127 | 14 | int:RHOF |
| Interaction | CIAO1 interactions | CCP110 TRAF5 DDX31 VPS13C EPB41L5 SMPD4 RICTOR CDKAL1 TRIM66 | 9.16e-05 | 289 | 127 | 9 | int:CIAO1 |
| Interaction | PFN1 interactions | TRIM15 VPS13C UBE2M KIDINS220 ISG15 MTFR1 SYNE2 SEC24B ANKRD28 MAP2K2 CNOT1 HTT | 9.17e-05 | 509 | 127 | 12 | int:PFN1 |
| Interaction | VASP interactions | 1.04e-04 | 294 | 127 | 9 | int:VASP | |
| Interaction | MAP2K6 interactions | 1.04e-04 | 74 | 127 | 5 | int:MAP2K6 | |
| Interaction | EEF1AKMT3 interactions | ERCC6L VPS13C CUL9 RICTOR SPG11 ELMO3 MAPK14 STIP1 ASCC3 MAP2K2 | 1.05e-04 | 364 | 127 | 10 | int:EEF1AKMT3 |
| Interaction | RND2 interactions | EPB41L5 SMPD4 RICTOR CDKAL1 PTPN13 KIDINS220 SYNE2 SEC23IP MARK2 MAP2K2 RAB32 | 1.09e-04 | 440 | 127 | 11 | int:RND2 |
| Interaction | HSP90AB1 interactions | RPL30 POLH UBR4 LRRK2 RICTOR UBE2M SPG11 MAPK14 AGO3 ISG15 SVIL STIP1 MARK2 MAPK13 MAP2K1 MAP2K2 HTT | 1.11e-04 | 960 | 127 | 17 | int:HSP90AB1 |
| Interaction | ANAPC2 interactions | 1.20e-04 | 234 | 127 | 8 | int:ANAPC2 | |
| Interaction | RPN2 interactions | SH3GL1 UBR4 BAG1 MECOM SMPD4 CDKAL1 ACSL4 SLC44A1 ISG15 SYNE2 SEC24B STIP1 ATXN10 CNOT1 KLC1 | 1.22e-04 | 782 | 127 | 15 | int:RPN2 |
| Interaction | DIAPH1 interactions | 1.27e-04 | 176 | 127 | 7 | int:DIAPH1 | |
| Interaction | DUSP16 interactions | 1.31e-04 | 237 | 127 | 8 | int:DUSP16 | |
| Interaction | NRAS interactions | CCP110 LRRC57 ERCC6L EPB41L5 RICTOR SHOC2 CDKAL1 ACSL4 SLC39A12 FAT1 KIDINS220 STXBP3 SEC23IP MARK2 | 1.33e-04 | 699 | 127 | 14 | int:NRAS |
| Interaction | SPSB4 interactions | 1.35e-04 | 124 | 127 | 6 | int:SPSB4 | |
| Interaction | VCL interactions | UBR1 CCP110 TRIM15 SH3GL1 EPB41L5 ITGB3 ASAP1 KIDINS220 SVIL | 1.38e-04 | 305 | 127 | 9 | int:VCL |
| Interaction | GSPT1 interactions | 1.41e-04 | 306 | 127 | 9 | int:GSPT1 | |
| Interaction | PSMD13 interactions | 1.41e-04 | 306 | 127 | 9 | int:PSMD13 | |
| Interaction | PRDX1 interactions | LRRK2 EPB41L5 MECOM RICTOR UBE2M MAPK14 ISG15 ALDH3A1 MAP2K2 HTT | 1.46e-04 | 379 | 127 | 10 | int:PRDX1 |
| Interaction | MBP interactions | 1.48e-04 | 126 | 127 | 6 | int:MBP | |
| Interaction | KIF2A interactions | 1.51e-04 | 242 | 127 | 8 | int:KIF2A | |
| Interaction | PSMB6 interactions | 1.56e-04 | 243 | 127 | 8 | int:PSMB6 | |
| Interaction | CAND1 interactions | CCP110 RPL30 DDX31 BAG1 RICTOR UBE2M ITGB3 AGO3 ISG15 SEC24B POP1 STIP1 DBR1 ASCC3 MTREX MAP2K1 | 1.60e-04 | 894 | 127 | 16 | int:CAND1 |
| Interaction | LCK interactions | EPB41L5 RICTOR CDKAL1 NEDD9 PTPN13 KIDINS220 PTPRC MAPK12 STIP1 MARK2 ARAP2 | 1.70e-04 | 463 | 127 | 11 | int:LCK |
| Interaction | FMNL2 interactions | 1.73e-04 | 185 | 127 | 7 | int:FMNL2 | |
| Interaction | PTK2 interactions | 1.75e-04 | 315 | 127 | 9 | int:PTK2 | |
| Interaction | EIF3G interactions | 1.84e-04 | 249 | 127 | 8 | int:EIF3G | |
| Interaction | TRIM52 interactions | 1.98e-04 | 133 | 127 | 6 | int:TRIM52 | |
| Interaction | ACTR2 interactions | 2.11e-04 | 323 | 127 | 9 | int:ACTR2 | |
| Interaction | ARHGEF2 interactions | 2.22e-04 | 256 | 127 | 8 | int:ARHGEF2 | |
| Interaction | ST13 interactions | 2.39e-04 | 195 | 127 | 7 | int:ST13 | |
| Interaction | CGAS interactions | 2.42e-04 | 329 | 127 | 9 | int:CGAS | |
| Interaction | H1-4 interactions | DDX31 BAG1 EPB41L5 GRB10 RICTOR UBE2M ASAP1 MTUS1 SVIL POP1 HELZ2 MAP2K1 HTT | 2.59e-04 | 656 | 127 | 13 | int:H1-4 |
| Interaction | DYNC1H1 interactions | HSPA4L LRRK2 CUL9 MECOM RICTOR ITGB3 ISG15 SEC23IP STIP1 KLC1 HTT | 2.81e-04 | 491 | 127 | 11 | int:DYNC1H1 |
| Interaction | SLC25A46 interactions | 2.95e-04 | 267 | 127 | 8 | int:SLC25A46 | |
| Interaction | RCOR1 interactions | ZCCHC8 POLH UBR4 USP24 MECOM TRIP4 TRIM66 PTPN13 DZIP3 ASCC3 KLC1 | 2.96e-04 | 494 | 127 | 11 | int:RCOR1 |
| Interaction | PTPRB interactions | 2.99e-04 | 51 | 127 | 4 | int:PTPRB | |
| Interaction | BAG5 interactions | 3.15e-04 | 341 | 127 | 9 | int:BAG5 | |
| Interaction | PDHB interactions | 3.22e-04 | 342 | 127 | 9 | int:PDHB | |
| Interaction | TRIM66 interactions | 3.24e-04 | 205 | 127 | 7 | int:TRIM66 | |
| Interaction | WWTR1 interactions | ERCC6L USP24 UBE2M PTPN13 SEC24B SEC23IP ASCC3 CNOT1 KLC1 HTT | 3.45e-04 | 422 | 127 | 10 | int:WWTR1 |
| Interaction | TRAPPC11 interactions | 3.55e-04 | 96 | 127 | 5 | int:TRAPPC11 | |
| Interaction | DNAJC7 interactions | HSPA4L VPS13C SMPD4 UBE2M SPG11 TTC3 SVIL STIP1 ATXN10 ASCC3 | 3.65e-04 | 425 | 127 | 10 | int:DNAJC7 |
| Interaction | KIF5B interactions | 3.65e-04 | 348 | 127 | 9 | int:KIF5B | |
| Interaction | RAB5C interactions | VPS13C EPB41L5 SMPD4 RICTOR TTC3 CDKAL1 KIDINS220 SEC24B SEC23IP STIP1 MARK2 MAP2K1 | 4.15e-04 | 600 | 127 | 12 | int:RAB5C |
| Interaction | AMHR2 interactions | 4.29e-04 | 56 | 127 | 4 | int:AMHR2 | |
| Interaction | RET interactions | 4.44e-04 | 284 | 127 | 8 | int:RET | |
| Interaction | DDB1 interactions | CCP110 POLH LRRK2 MECOM RICTOR UBE2M ISG15 DZIP3 EXO1 STIP1 KLC1 HTT DYRK2 | 4.62e-04 | 697 | 127 | 13 | int:DDB1 |
| Interaction | INF2 interactions | 4.87e-04 | 288 | 127 | 8 | int:INF2 | |
| Interaction | LINC01587 interactions | 5.08e-04 | 25 | 127 | 3 | int:LINC01587 | |
| Interaction | FIS1 interactions | 5.09e-04 | 221 | 127 | 7 | int:FIS1 | |
| Interaction | CAMK4 interactions | 5.24e-04 | 59 | 127 | 4 | int:CAMK4 | |
| Interaction | CYP2C9 interactions | 5.36e-04 | 105 | 127 | 5 | int:CYP2C9 | |
| Interaction | DCAF7 interactions | 5.47e-04 | 368 | 127 | 9 | int:DCAF7 | |
| Interaction | RAC3 interactions | EPB41L5 SMPD4 RICTOR CDKAL1 ASAP1 ADGRG6 FAT1 PTPN13 KIDINS220 STXBP3 MARK2 ARAP2 | 5.48e-04 | 619 | 127 | 12 | int:RAC3 |
| Interaction | ZFPL1 interactions | EPB41L5 SMPD4 IVL SLC39A12 PTPN13 KIDINS220 STXBP3 SEC24B SEC23IP MARK2 | 5.51e-04 | 448 | 127 | 10 | int:ZFPL1 |
| Interaction | GRB10 interactions | 5.52e-04 | 161 | 127 | 6 | int:GRB10 | |
| Interaction | STYK1 interactions | 5.52e-04 | 161 | 127 | 6 | int:STYK1 | |
| Interaction | USP7 interactions | ANKRD31 CCP110 TRAF5 ERCC6L ZCCHC8 POLH LRRK2 USP24 KLC2 MECOM SHOC2 ITGB3 LRRC3B SCN2A SVIL POP1 STIP1 MTREX KLC1 | 5.68e-04 | 1313 | 127 | 19 | int:USP7 |
| Interaction | CRK interactions | 5.69e-04 | 370 | 127 | 9 | int:CRK | |
| Interaction | MIB1 interactions | 5.71e-04 | 295 | 127 | 8 | int:MIB1 | |
| Interaction | ZHX1-C8orf76 interactions | 5.72e-04 | 26 | 127 | 3 | int:ZHX1-C8orf76 | |
| Interaction | ANKRD17 interactions | 5.82e-04 | 226 | 127 | 7 | int:ANKRD17 | |
| Interaction | AP2B1 interactions | CCP110 LONRF1 THAP1 CFAP54 KIDINS220 ISG15 ANKRD28 STIP1 HTT | 6.03e-04 | 373 | 127 | 9 | int:AP2B1 |
| Interaction | GJD3 interactions | VPS13C EPB41L5 SMPD4 CDKAL1 PTPN13 KIDINS220 SYNE2 SEC24B SEC23IP MARK2 | 6.10e-04 | 454 | 127 | 10 | int:GJD3 |
| Interaction | NTRK3 interactions | HSPA4L SH3GL1 RICTOR CDKAL1 ACSL4 PTPN13 KIDINS220 SEC24B SEC23IP | 6.14e-04 | 374 | 127 | 9 | int:NTRK3 |
| GeneFamily | Mitogen-activated protein kinases | 3.29e-05 | 13 | 90 | 3 | 651 | |
| GeneFamily | RNA binding motif containing|Nuclear exosome targeting complex | 7.33e-05 | 3 | 90 | 2 | 1316 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.73e-04 | 115 | 90 | 5 | 769 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 5.06e-04 | 7 | 90 | 2 | 653 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 5.06e-04 | 7 | 90 | 2 | 785 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.31e-03 | 11 | 90 | 2 | 1168 | |
| GeneFamily | CD molecules|Membrane spanning 4-domains | 3.56e-03 | 18 | 90 | 2 | 958 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP24 MECOM SPG11 SHOC2 ZNF804A ADGRG6 ACSL4 FAT1 PTPN13 MAPK14 KIDINS220 STXBP3 MTIF2 MTFR1 ATAD2B SYNE2 SEC24B ANKRD28 ASCC3 MTREX MAP2K1 KLC1 ARAP2 | 2.26e-11 | 856 | 127 | 23 | M4500 |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 5.97e-07 | 200 | 127 | 9 | M9889 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN | 6.16e-06 | 200 | 127 | 8 | M8849 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP | 6.16e-06 | 200 | 127 | 8 | M7649 | |
| Coexpression | GSE17721_0.5H_VS_4H_LPS_BMDC_DN | 6.16e-06 | 200 | 127 | 8 | M4073 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | UBR1 RPL30 TRAF5 VPS13C UBR4 USP24 RICTOR SPG11 ASAP1 NEDD9 ACSL4 KIDINS220 PTPRC DZIP3 ANKRD28 ASCC3 MAP2K1 CNOT1 KLC1 ARAP2 DYRK2 | 9.81e-06 | 1492 | 127 | 21 | M40023 |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP | 1.39e-05 | 107 | 127 | 6 | M7141 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | UBR1 ERCC6L ZCCHC8 LONRF1 GRB10 THAP1 GFM2 CDKAL1 ASAP1 ACSL4 MTFR1 POP1 EXO1 AK2 STIP1 DBR1 MAP2K1 MAP2K2 CNOT1 | 1.47e-05 | 1290 | 127 | 19 | M80 |
| Coexpression | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR | MS4A6E ZCCHC8 USP24 ASAP1 MTUS1 MTFR1 PRKAR2B ANKRD28 ATXN10 MAP2K1 RAB32 HDC | 1.50e-05 | 548 | 127 | 12 | MM1013 |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 1.77e-05 | 167 | 127 | 7 | M361 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MPP3 LONRF1 LRRK2 RICTOR TTC3 ACSL4 SLC39A12 FRY MTUS1 LRRC3B SCN2A PRKAR2B CDH4 UNC79 UNC13A KLC1 DYRK2 | 2.53e-05 | 1106 | 127 | 17 | M39071 |
| Coexpression | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR | ZCCHC8 USP24 ASAP1 MTUS1 MTFR1 PRKAR2B ANKRD28 ATXN10 MAP2K1 RAB32 HDC | 4.41e-05 | 516 | 127 | 11 | M11166 |
| Coexpression | HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN | 4.63e-05 | 41 | 127 | 4 | M41184 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN | 5.25e-05 | 198 | 127 | 7 | M4272 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 5.25e-05 | 198 | 127 | 7 | M4415 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP | 5.42e-05 | 199 | 127 | 7 | M5694 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP | 5.59e-05 | 200 | 127 | 7 | M6256 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 5.59e-05 | 200 | 127 | 7 | M9030 | |
| Coexpression | GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP | 5.59e-05 | 200 | 127 | 7 | M5559 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP | 5.59e-05 | 200 | 127 | 7 | M5610 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | RGPD4 ATP8B4 ZNF804A THAP1 FAT1 GALNT17 ASCC3 IL17RD CDH4 DYRK2 | 5.63e-05 | 438 | 127 | 10 | M227 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | RGPD4 ATP8B4 GRB10 ZNF804A THAP1 RANBP17 FAT1 GALNT17 ATAD2B SVIL ASCC3 MTREX IL17RD CDH4 DYRK2 | 1.14e-04 | 1009 | 127 | 15 | M157 |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | ADH6 ACSL4 PTPN13 KIDINS220 PTPRC STXBP3 ATAD2B SEC24B EXO1 PRKAR2B ANKRD28 ARAP2 | 1.68e-04 | 705 | 127 | 12 | M1410 |
| Coexpression | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP | 2.31e-04 | 5 | 127 | 2 | M1336 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP | 2.74e-04 | 183 | 127 | 6 | M6670 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN | 3.26e-04 | 189 | 127 | 6 | M4261 | |
| Coexpression | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP | 3.45e-04 | 6 | 127 | 2 | MM555 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | HSPA4L ORC3 VPS13C SPG11 THAP1 PTPN13 KIDINS220 STXBP3 MTUS1 SYNE2 MTREX | 3.58e-04 | 656 | 127 | 11 | M18979 |
| Coexpression | CHEN_ETV5_TARGETS_SERTOLI | 3.70e-04 | 29 | 127 | 3 | MM675 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP | 3.85e-04 | 195 | 127 | 6 | M8872 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_DN | 3.85e-04 | 195 | 127 | 6 | M3170 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN | 4.06e-04 | 197 | 127 | 6 | M4294 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP | 4.17e-04 | 198 | 127 | 6 | M5584 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH2_UP | 4.17e-04 | 198 | 127 | 6 | M5455 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP | 4.29e-04 | 199 | 127 | 6 | M8351 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 4.29e-04 | 199 | 127 | 6 | M3440 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_24H_BMDC_DN | 4.29e-04 | 199 | 127 | 6 | M3821 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP | 4.29e-04 | 199 | 127 | 6 | M8727 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 4.29e-04 | 199 | 127 | 6 | M7756 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP | 4.29e-04 | 199 | 127 | 6 | M5599 | |
| Coexpression | GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN | 4.29e-04 | 199 | 127 | 6 | M4161 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | 4.29e-04 | 199 | 127 | 6 | M9269 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 4.40e-04 | 200 | 127 | 6 | M8030 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 4.40e-04 | 200 | 127 | 6 | M8090 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 4.40e-04 | 200 | 127 | 6 | M9327 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN | 4.40e-04 | 200 | 127 | 6 | M4531 | |
| Coexpression | GSE27786_LSK_VS_NKTCELL_UP | 4.40e-04 | 200 | 127 | 6 | M4754 | |
| Coexpression | GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN | 4.40e-04 | 200 | 127 | 6 | M8654 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_2H_BMDC_UP | 4.40e-04 | 200 | 127 | 6 | M3937 | |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP | 4.40e-04 | 200 | 127 | 6 | M7489 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN | 4.40e-04 | 200 | 127 | 6 | M5088 | |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP | 4.40e-04 | 200 | 127 | 6 | M6357 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP | 4.40e-04 | 200 | 127 | 6 | M7980 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP | 4.40e-04 | 200 | 127 | 6 | M6606 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 4.40e-04 | 200 | 127 | 6 | M6531 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 4.40e-04 | 200 | 127 | 6 | M7841 | |
| Coexpression | GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN | 4.40e-04 | 200 | 127 | 6 | M7833 | |
| Coexpression | GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN | 4.40e-04 | 200 | 127 | 6 | M9020 | |
| Coexpression | GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN | 4.40e-04 | 200 | 127 | 6 | M4239 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_DC_DN | 4.40e-04 | 200 | 127 | 6 | M4465 | |
| Coexpression | GSE7831_1H_VS_4H_CPG_STIM_PDC_UP | 4.40e-04 | 200 | 127 | 6 | M6960 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 4.51e-04 | 567 | 127 | 10 | M1097 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 4.58e-04 | 466 | 127 | 9 | M13522 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL | 4.98e-04 | 375 | 127 | 8 | M45799 | |
| CoexpressionAtlas | Myeloid Cells, GN.BM, CD11b+ Ly6-G+, Bone marrow, avg-4 | AMPD3 ATP8B4 LRRK2 CMPK2 MTUS1 SVIL SYNE2 PRKAR2B MAPK13 RAB32 MCTP2 HDC | 7.53e-06 | 415 | 127 | 12 | GSM605846_500 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.87e-08 | 186 | 128 | 8 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.61e-08 | 127 | 128 | 7 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-07 | 200 | 128 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.55e-07 | 167 | 128 | 7 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 7.60e-07 | 175 | 128 | 7 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-07 | 176 | 128 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | lung|World / shred on tissue and cell subclass | 8.52e-07 | 178 | 128 | 7 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.52e-07 | 181 | 128 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.52e-07 | 181 | 128 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-07 | 182 | 128 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 185 | 128 | 7 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 185 | 128 | 7 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 186 | 128 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.36e-06 | 191 | 128 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.36e-06 | 191 | 128 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.41e-06 | 192 | 128 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.46e-06 | 193 | 128 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 1.57e-06 | 195 | 128 | 7 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 195 | 128 | 7 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 197 | 128 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 197 | 128 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-06 | 198 | 128 | 7 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-NK_CD56bright|IIF / Disease, condition lineage and cell class | 1.79e-06 | 199 | 128 | 7 | 9eb2b7d4900b118338590db778a47504559e228d | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.85e-06 | 200 | 128 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.96e-06 | 145 | 128 | 6 | dc89d817a9bef24a07e992efdab4136f12ceb399 | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 5.20e-06 | 152 | 128 | 6 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 7.76e-06 | 163 | 128 | 6 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-06 | 165 | 128 | 6 | b671c6a950e70f64776c2104baccb3dc2bb6a1ba | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 171 | 128 | 6 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 171 | 128 | 6 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 172 | 128 | 6 | 13d7117f92a92d77d6b4335ed800c585dc8b4511 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 172 | 128 | 6 | 3d83b2f03ad3af4dae3fe6cc0a0ef356872ca94f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 172 | 128 | 6 | a3d431aed12c1192e8dca1dc85b8340fb7354f8d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 172 | 128 | 6 | 1bbf5ed7d13635f9a7e528060341e0652699bd7c | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 172 | 128 | 6 | 028a5441242b2cc760cafc1822120180619c63ae | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 172 | 128 | 6 | 9fc70b1a143a8ec910336c23b761d908bb6aecb2 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 177 | 128 | 6 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 177 | 128 | 6 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 177 | 128 | 6 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-05 | 179 | 128 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Basophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.50e-05 | 183 | 128 | 6 | 93d821d5340caed0eef455d3d738be213ce5fff8 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 185 | 128 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-05 | 185 | 128 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.59e-05 | 185 | 128 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.64e-05 | 186 | 128 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 187 | 128 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.75e-05 | 188 | 128 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.75e-05 | 188 | 128 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 188 | 128 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.75e-05 | 188 | 128 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.80e-05 | 189 | 128 | 6 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 189 | 128 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-05 | 189 | 128 | 6 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.80e-05 | 189 | 128 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.80e-05 | 189 | 128 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-05 | 190 | 128 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.91e-05 | 191 | 128 | 6 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.91e-05 | 191 | 128 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-05 | 191 | 128 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.97e-05 | 192 | 128 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.97e-05 | 192 | 128 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.03e-05 | 193 | 128 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 193 | 128 | 6 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.03e-05 | 193 | 128 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.09e-05 | 194 | 128 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-05 | 194 | 128 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-HSC-MPP|bone_marrow / Manually curated celltypes from each tissue | 2.09e-05 | 194 | 128 | 6 | 3a7e7acbddc63da44d9a04a5b52adf6934fc83dd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-05 | 194 | 128 | 6 | 9d7f232ef5f27c28f325edfa6614f479013acbba | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.15e-05 | 195 | 128 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-05 | 195 | 128 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.15e-05 | 195 | 128 | 6 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-05 | 196 | 128 | 6 | ed76eeb37400ca154feae9b7ebaddb6c434f8b81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 196 | 128 | 6 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 196 | 128 | 6 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | CV-Severe|CV / Virus stimulation, Condition and Cluster | 2.21e-05 | 196 | 128 | 6 | d0ddeaaa9ad0576e312a49bd3e68d12addccad3c | |
| ToppCell | mild-Myeloid-Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.21e-05 | 196 | 128 | 6 | e9f30eb8a3915c3b2af009c832bff9b349b65ae5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 2.27e-05 | 197 | 128 | 6 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 2.27e-05 | 197 | 128 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.27e-05 | 197 | 128 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.27e-05 | 197 | 128 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC-29|World / Primary Cells by Cluster | 2.27e-05 | 197 | 128 | 6 | c5bc0e7eb85642b270efc2ba92b13a736af22052 | |
| ToppCell | CV-Severe-1|CV / Virus stimulation, Condition and Cluster | 2.34e-05 | 198 | 128 | 6 | fc0e885e370ffb780eada62bb2b52065c2f8b26b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 198 | 128 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.34e-05 | 198 | 128 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.34e-05 | 198 | 128 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 2.34e-05 | 198 | 128 | 6 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.34e-05 | 198 | 128 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-05 | 199 | 128 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.41e-05 | 199 | 128 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 2.41e-05 | 199 | 128 | 6 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 2.41e-05 | 199 | 128 | 6 | 7b21447bb39cdba37539a12cb475f463010fc23f | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.41e-05 | 199 | 128 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.41e-05 | 199 | 128 | 6 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 128 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.47e-05 | 200 | 128 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_CD56bright|Control / Disease, condition lineage and cell class | 2.47e-05 | 200 | 128 | 6 | d843fe0781c7699afead4429c526441c6fdb8cba | |
| ToppCell | mLN-Mast_cell-Mast|mLN / Region, Cell class and subclass | 2.47e-05 | 200 | 128 | 6 | 81ea6e7a3940277751faf9097b30198159998c7b | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 128 | 6 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | mLN-Mast_cell|mLN / Region, Cell class and subclass | 2.47e-05 | 200 | 128 | 6 | 9a5f1d99d8d160923d4d0fbbf9ad48a26f8a4fad | |
| ToppCell | mLN-(7)_Mast_cell-(70)_Mast|mLN / shred on region, Cell_type, and subtype | 2.47e-05 | 200 | 128 | 6 | a6c258cae678be581b1d85cf3446c65c34b13499 | |
| Drug | Ac2-26 | 6.91e-07 | 4 | 128 | 3 | CID000568638 | |
| Drug | NSC-68458 | 6.91e-07 | 4 | 128 | 3 | CID000249771 | |
| Drug | K00039 | 9.26e-07 | 32 | 128 | 5 | CID009549277 | |
| Drug | methyl ethyl ketone | UBR1 GRB10 SHOC2 ITGB3 IVL NEDD9 MAPK14 MAPK12 PRKAR2B MAPK13 IL17RD CXCL6 MAP2K1 MAP2K2 DYRK2 | 1.12e-06 | 587 | 128 | 15 | CID000006569 |
| Drug | AC1NSKHR | 1.27e-06 | 34 | 128 | 5 | CID005311362 | |
| Drug | Ro 31 | 1.36e-06 | 141 | 128 | 8 | CID000214797 | |
| Drug | Iressa; Down 200; 10uM; HL60; HG-U133A | 1.63e-06 | 195 | 128 | 9 | 541_DN | |
| Drug | AMP 579 | 1.65e-06 | 16 | 128 | 4 | CID006918429 | |
| Drug | pyridinyl imidazole | 1.70e-06 | 36 | 128 | 5 | CID000005171 | |
| Drug | nickel hydroxide | TRAF5 GRB10 UBE2M NEDD9 MAPK14 PTPRC MAPK12 MAPK13 MAP2K1 MAP2K2 | 2.13e-06 | 259 | 128 | 10 | CID000025500 |
| Drug | Go6983 | 2.92e-06 | 40 | 128 | 5 | CID000003499 | |
| Drug | tolyltriazole | 3.43e-06 | 6 | 128 | 3 | CID000025902 | |
| Drug | n-sulfo-2-aminotricarballylate | 4.31e-06 | 20 | 128 | 4 | CID000135808 | |
| Drug | Cp-38 | 5.98e-06 | 7 | 128 | 3 | CID006918286 | |
| Drug | satratoxin H | 5.98e-06 | 7 | 128 | 3 | CID000434380 | |
| Drug | 2,2',4,6-tetrachlorobiphenyl | 5.98e-06 | 7 | 128 | 3 | CID000044163 | |
| Drug | CID6325568 | 5.98e-06 | 7 | 128 | 3 | CID006325568 | |
| Drug | SKF86002 | 9.28e-06 | 24 | 128 | 4 | CID000005228 | |
| Drug | Z-D-CH2DCB | 9.52e-06 | 8 | 128 | 3 | CID009911778 | |
| Drug | ML3403 | 9.52e-06 | 8 | 128 | 3 | CID006419739 | |
| Drug | Magnetite Nanoparticles | RPL30 AMPD3 TRAF5 ORC3 CMPK2 MECOM SMPD4 TTC3 ZNF804A NEDD9 ACSL4 ZBP1 SLC44A1 PTPRC ISG15 DZIP3 EXO1 PRKAR2B MTREX UNC13A HDC | 1.29e-05 | 1310 | 128 | 21 | ctd:D058185 |
| Drug | AC1NSK9Q | 1.29e-05 | 26 | 128 | 4 | CID005311233 | |
| Drug | Avermectin B1 [71751-41-2]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.33e-05 | 192 | 128 | 8 | 7218_UP | |
| Drug | SC68376 | 1.42e-05 | 9 | 128 | 3 | CID000005174 | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.44e-05 | 194 | 128 | 8 | 1823_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.61e-05 | 197 | 128 | 8 | 6507_DN | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; HL60; HG-U133A | 1.73e-05 | 199 | 128 | 8 | 2028_DN | |
| Drug | AC1NOLIT | 2.02e-05 | 10 | 128 | 3 | CID005090286 | |
| Drug | 2-ketobenzothiazole 23 | 2.21e-05 | 60 | 128 | 5 | CID003348131 | |
| Drug | Succimer | RPL30 AMPD3 TRAF5 ORC3 CMPK2 MECOM SMPD4 TTC3 ZNF804A ACSL4 ZBP1 SLC44A1 PTPRC ISG15 DZIP3 EXO1 PRKAR2B MTREX UNC13A HDC | 2.57e-05 | 1264 | 128 | 20 | ctd:D004113 |
| Drug | CGP57380 | 2.67e-05 | 31 | 128 | 4 | CID011644425 | |
| Drug | nemorosone | 2.77e-05 | 11 | 128 | 3 | CID000637105 | |
| Drug | TAK 733 | 3.14e-05 | 2 | 128 | 2 | ctd:C558666 | |
| Drug | N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | 3.14e-05 | 2 | 128 | 2 | ctd:C544830 | |
| Drug | sesamolin | 3.68e-05 | 12 | 128 | 3 | CID000101746 | |
| Drug | AC1L1JGQ | 5.74e-05 | 73 | 128 | 5 | CID000005034 | |
| Drug | SB-242235 | 6.04e-05 | 14 | 128 | 3 | CID009863367 | |
| Drug | SB202474 | 6.04e-05 | 14 | 128 | 3 | CID000005162 | |
| Drug | CPI-1189 | 6.04e-05 | 14 | 128 | 3 | CID000151118 | |
| Drug | vanadyl | MAPK14 PTPRC MAPK12 MTUS1 PRKAR2B MAPK13 MAP2K1 MAP2K2 DNAH11 | 6.14e-05 | 307 | 128 | 9 | CID000061671 |
| Drug | tyrphostin 25 | 6.66e-05 | 122 | 128 | 6 | CID000002061 | |
| Drug | MMP-2 Inhibitor I | 7.52e-05 | 15 | 128 | 3 | CID000004220 | |
| Drug | 3 SA | 8.21e-05 | 41 | 128 | 4 | CID000449164 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.92e-05 | 186 | 128 | 7 | 966_DN | |
| Drug | SD-282 | 9.21e-05 | 16 | 128 | 3 | CID014973220 | |
| Drug | SB 239063 | 9.21e-05 | 16 | 128 | 3 | CID000005166 | |
| Drug | RO5126766 | 9.37e-05 | 3 | 128 | 2 | ctd:C577924 | |
| Drug | 2f34 | 9.54e-05 | 188 | 128 | 7 | CID006420160 | |
| Drug | Go6976 | 1.02e-04 | 190 | 128 | 7 | CID000003501 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.05e-04 | 191 | 128 | 7 | 4168_DN | |
| Drug | Ambotz208527-57-5 | 1.11e-04 | 17 | 128 | 3 | CID010258704 | |
| Drug | dracorhodin | 1.11e-04 | 17 | 128 | 3 | CID000069509 | |
| Drug | kazinol B | 1.11e-04 | 17 | 128 | 3 | CID000480869 | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; HL60; HT_HG-U133A | 1.12e-04 | 193 | 128 | 7 | 1860_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.16e-04 | 194 | 128 | 7 | 7214_DN | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.16e-04 | 194 | 128 | 7 | 5328_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.16e-04 | 194 | 128 | 7 | 7001_DN | |
| Drug | AC1Q5V5T | 1.17e-04 | 135 | 128 | 6 | CID000004701 | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 195 | 128 | 7 | 4781_DN | |
| Drug | C11102 | 1.26e-04 | 86 | 128 | 5 | CID000443069 | |
| Drug | Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 3201_UP | |
| Drug | adaphostin | 1.30e-04 | 46 | 128 | 4 | CID000387042 | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 6778_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 6228_DN | |
| Drug | MPC-1304 | 1.33e-04 | 87 | 128 | 5 | CID000002225 | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.36e-04 | 199 | 128 | 7 | 5006_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.36e-04 | 199 | 128 | 7 | 6968_DN | |
| Drug | AMPK inhibitor | 1.48e-04 | 89 | 128 | 5 | CID011524144 | |
| Drug | NIH-3 | 1.57e-04 | 19 | 128 | 3 | CID009822007 | |
| Drug | Thr-Gly | 1.57e-04 | 19 | 128 | 3 | CID006427013 | |
| Drug | benzenesulfonyl fluoride | 1.66e-04 | 49 | 128 | 4 | CID000067779 | |
| Drug | compound 9b | 1.84e-04 | 20 | 128 | 3 | CID000207510 | |
| Drug | DB02873 | 1.87e-04 | 4 | 128 | 2 | CID004630909 | |
| Drug | Pkcs | 1.95e-04 | 211 | 128 | 7 | CID000164073 | |
| Drug | AG126 | 2.11e-04 | 96 | 128 | 5 | CID000002046 | |
| Drug | L0168 | 2.14e-04 | 21 | 128 | 3 | CID000445856 | |
| Drug | inhibitor of p38 kinase | 2.25e-04 | 53 | 128 | 4 | CID000027933 | |
| Drug | geldanamycin | 2.55e-04 | 371 | 128 | 9 | ctd:C001277 | |
| Disease | mean platelet volume | MPP3 LRRC66 ATP8B4 LRRK2 MECOM ITGB3 SVEP1 ASAP1 ACSL4 FRY PTPRC ATAD2B SVIL SYNE2 ANKRD28 STIP1 MAP2K1 HTT | 2.78e-07 | 1020 | 124 | 18 | EFO_0004584 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.71e-06 | 222 | 124 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | RASopathy (implicated_via_orthology) | 5.97e-06 | 9 | 124 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Noonan Syndrome 1 | 1.17e-05 | 11 | 124 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 1.17e-05 | 11 | 124 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.17e-05 | 11 | 124 | 3 | C1527404 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.66e-05 | 264 | 124 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | small intestine adenocarcinoma (is_implicated_in) | 5.24e-05 | 3 | 124 | 2 | DOID:4906 (is_implicated_in) | |
| Disease | response to clozapine | 5.64e-05 | 18 | 124 | 3 | GO_0097338 | |
| Disease | waist-hip ratio | AMPD3 GRB10 CUL9 MECOM ITGB3 CDKAL1 NEDD9 TRIM66 SLC44A1 KIDINS220 LRRC3B SCN2A SYNE2 ANKRD28 IL17RD HTT | 5.72e-05 | 1226 | 124 | 16 | EFO_0004343 |
| Disease | FEV/FEC ratio | ZNF438 AMPD3 ATP8B4 VPS13C EPB41L5 MECOM ASAP1 ADGRG6 TG MTUS1 SVIL SYNE2 RASGEF1C ATXN10 ARAP2 HDC | 5.83e-05 | 1228 | 124 | 16 | EFO_0004713 |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 6.68e-05 | 19 | 124 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 6.68e-05 | 19 | 124 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 6.68e-05 | 19 | 124 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 6.68e-05 | 19 | 124 | 3 | C0587248 | |
| Disease | LEOPARD Syndrome | 1.05e-04 | 22 | 124 | 3 | C0175704 | |
| Disease | Noonan Syndrome | 1.37e-04 | 24 | 124 | 3 | C0028326 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.38e-04 | 291 | 124 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | colipase measurement | 2.60e-04 | 6 | 124 | 2 | EFO_0801485 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 2.60e-04 | 6 | 124 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | level of Sphingomyelin (d38:1) in blood serum | 2.71e-04 | 30 | 124 | 3 | OBA_2045180 | |
| Disease | response to aromatase inhibitor | 3.29e-04 | 32 | 124 | 3 | GO_0061477 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 3.63e-04 | 7 | 124 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 4.40e-04 | 150 | 124 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | colon cancer (is_implicated_in) | 4.67e-04 | 36 | 124 | 3 | DOID:219 (is_implicated_in) | |
| Disease | insulin sensitivity measurement, insulin response measurement | 4.82e-04 | 8 | 124 | 2 | EFO_0004471, EFO_0008473 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 5.99e-04 | 91 | 124 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | insulin response measurement | 6.19e-04 | 9 | 124 | 2 | EFO_0008473 | |
| Disease | body height at birth | 6.39e-04 | 40 | 124 | 3 | EFO_0006784 | |
| Disease | melanoma | 6.48e-04 | 248 | 124 | 6 | C0025202 | |
| Disease | high grade glioma (is_implicated_in) | 7.38e-04 | 42 | 124 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 8.53e-04 | 100 | 124 | 4 | C0010606 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 8.99e-04 | 364 | 124 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | urate measurement, bone density | 1.24e-03 | 619 | 124 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 1.54e-03 | 14 | 124 | 2 | EFO_0008212 | |
| Disease | unipolar depression | TRIM15 HSPA4L ZNF804A CDKAL1 ADGRG6 FAT1 GALNT17 SVIL SYNE2 ASCC3 CDH4 KLC1 HTT | 1.72e-03 | 1206 | 124 | 13 | EFO_0003761 |
| Disease | Graves' disease (is_marker_for) | 1.77e-03 | 15 | 124 | 2 | DOID:12361 (is_marker_for) | |
| Disease | RASopathy | 1.77e-03 | 15 | 124 | 2 | cv:C5555857 | |
| Disease | Malignant neoplasm of breast | ZNF438 POLH UBR4 BAG1 MECOM TTC3 SLC39A12 PTPRC LRRC3B SYNE2 POP1 EXO1 | 1.93e-03 | 1074 | 124 | 12 | C0006142 |
| Disease | myeloid white cell count | AMPD3 MECOM CDKAL1 SLC39A12 SLC44A1 GALNT17 PTPRC ATAD2B CXCL6 MAP2K2 HTT | 2.03e-03 | 937 | 124 | 11 | EFO_0007988 |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.39e-03 | 63 | 124 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.39e-03 | 63 | 124 | 3 | EFO_0022239 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.66e-03 | 225 | 124 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | Omenn Syndrome | 2.86e-03 | 19 | 124 | 2 | C2700553 | |
| Disease | Severe Combined Immunodeficiency | 3.17e-03 | 20 | 124 | 2 | C0085110 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.25e-03 | 144 | 124 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.33e-03 | 145 | 124 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Alzheimer disease, age at onset | 3.35e-03 | 343 | 124 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.45e-03 | 239 | 124 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 4.18e-03 | 23 | 124 | 2 | OBA_2045181 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNQSFEIIKKLECPD | 1196 | Q9UPW8 | |
| GKVEAALKNCPLIDN | 586 | O60488 | |
| DAKNPLLASCEKEIQ | 66 | Q96N23 | |
| LAINKPQNKCDDLDR | 516 | Q14511 | |
| KKAQELGATECLNPQ | 231 | P28332 | |
| KVNELDGIPLILDNC | 391 | Q9UBB4 | |
| CLLNNALPVKEKEDI | 231 | Q86SQ4 | |
| LCDPSIQNQIVEKLK | 251 | P30838 | |
| ANKAVKCAEALVPLL | 116 | O15084 | |
| QKQRECEADLLKAEP | 3171 | Q96DT5 | |
| FLPKDLQAEALCKLD | 261 | Q99933 | |
| ELNKALCAAVVKPDV | 811 | Q8WZ64 | |
| DGIVVCEVPNNKLDK | 196 | Q8TF62 | |
| KLLANCFQVEIPKID | 31 | Q9H9G7 | |
| VASLKNGKQVCLDPE | 81 | P80162 | |
| DCPIGQKEAKERELQ | 46 | Q01432 | |
| CLIKNPAERADLKQL | 341 | Q02750 | |
| VNKCLIKNPAERADL | 346 | P36507 | |
| LKEVFAKPLNLQDQC | 196 | Q9H2T7 | |
| IPAVLLANKCDQNKD | 136 | Q13637 | |
| DCLLELIEQKGEKPN | 291 | Q5T6V5 | |
| KPLNDQEKEKLALEC | 501 | Q9UPP5 | |
| NNKLTVLPDEICNLK | 71 | Q8N9N7 | |
| NNIGVLPEELCDLKK | 186 | Q6ZNQ3 | |
| KECDQVFPDLQSLEK | 266 | Q03112 | |
| KILPKILGCEDLTNN | 411 | Q8N7Z5 | |
| PNCLTENVLKEIAKA | 416 | P19113 | |
| VKVLDANDNSPVCEK | 3011 | Q14517 | |
| LEIVKELIKNGANCN | 51 | Q9ULH0 | |
| EGRQCQQLILKDPKQ | 121 | Q8NFM7 | |
| KVDISALPLKQANCL | 436 | Q6DN12 | |
| INEAKKNCIIVPNGD | 146 | A8MVJ9 | |
| AKDAQVPIILAVNKC | 276 | P46199 | |
| LKNIPDSKEAPVNLC | 461 | Q9ULD2 | |
| LKPSNLAVNEDCELK | 151 | Q16539 | |
| DFAPAKLQVQKILCD | 311 | Q17RB8 | |
| KLEALECSNNEKLEP | 1331 | Q9ULI0 | |
| DKCDEPLSILVRNNK | 76 | P05161 | |
| ELIEKNLETPLCKNG | 81 | P54819 | |
| EGLKPKAEDLDACNL | 891 | Q86VH2 | |
| EQLQKVQALCLPLDK | 216 | Q9BX97 | |
| LKPGNLAVNEDCELK | 151 | O15264 | |
| PANDEVQKLGCKALH | 171 | Q5S007 | |
| LNAANDADLCNLPKK | 186 | Q96PB8 | |
| DQLNPKDKAVQEVCP | 451 | Q9H8H2 | |
| ENVIPDILKLAKQCE | 946 | Q6R327 | |
| NKELPQSKQFDLCLL | 456 | Q86Y13 | |
| GKKEDAPQDLALAVC | 366 | Q68CR7 | |
| TQDENGKKQLPDCIV | 686 | Q9NXE4 | |
| VAVPLCKQALEDLEK | 216 | Q9H0B6 | |
| KTPALANEEALQKIC | 131 | Q15390 | |
| SKALPNPEKCQDNEK | 521 | Q99575 | |
| ENANPECQSAIKPLK | 481 | Q9HDB9 | |
| VLDLVDQCPKQIQKG | 236 | Q5EBM0 | |
| LQLKQDILSGKLDCP | 141 | Q9HCM4 | |
| CLEQQPRNKPLKALD | 2526 | P42858 | |
| AQEENKKIVLAGCVP | 126 | Q5VV42 | |
| KFDPKVDDNALQCLE | 411 | O95395 | |
| NAPELLPKEAQICEK | 611 | P55283 | |
| LPKEAQICEKPNLNA | 616 | P55283 | |
| NNKAKDVCLDQGPLE | 471 | Q6IS24 | |
| AKLNLLTCQVKPNAE | 366 | Q9ULH1 | |
| KIAGILPLDNEDQCK | 141 | O43303 | |
| QAKPLAAVLKEVCDA | 26 | Q96BJ8 | |
| AQVEKVPKLLCQDSE | 631 | Q96JA4 | |
| AALNPASLQCKLDEK | 76 | Q96DS6 | |
| DCENLLKKFLILNPS | 276 | Q7KZI7 | |
| LKENLLKDNCAPESI | 66 | P05106 | |
| QEACKDILLFKNLDP | 146 | P31323 | |
| HQKIKNFQILPCEDD | 536 | Q13322 | |
| IKKLDLCEQQPIFQN | 506 | Q8IWT3 | |
| DPCNLDLINRKIKSV | 96 | Q8WWI5 | |
| EVLEKLNHDLKVPCN | 326 | Q9UK59 | |
| AQVCLEEKNPKLSNL | 2171 | Q5TBA9 | |
| LEALLKALKSECQGQ | 431 | Q5M9N0 | |
| QQLKALCEKHGDRVP | 1561 | Q9BYK8 | |
| APVPNLNADLKKLNC | 541 | O95487 | |
| IEKCFILLVSPNDKQ | 461 | Q504Y0 | |
| HCDLKPENILLKQQG | 346 | Q92630 | |
| LALKECILALGQNKP | 476 | Q8N4N8 | |
| NCLVKALDIKSADPE | 1221 | Q2NKX8 | |
| VAVPLCKQALEDLEK | 231 | Q07866 | |
| QELKPLDQCLIGQTK | 2221 | Q12923 | |
| NVDNGKEELCKPNLV | 291 | Q5THK1 | |
| KNEALKSEEGCIPNI | 611 | Q9UBD5 | |
| NKVCLVDVEPEALKQ | 476 | Q13368 | |
| LRPLNLEEENKKCQD | 296 | Q5VT97 | |
| KQKFEECQQLLLDIP | 1161 | Q7Z3J3 | |
| KQPDLEHALKCLQRE | 501 | Q969S9 | |
| NPDLALEEKNKGNEC | 356 | P31948 | |
| AANKIKEQCPLEAGL | 1941 | O95425 | |
| VLELSPKELDEKNCQ | 3141 | Q8WXH0 | |
| KIKQLPAEIGELCNL | 226 | Q9UQ13 | |
| DDAKKLCPDLLLAQV | 66 | Q9Y253 | |
| DILSNQKDLNLSKCP | 591 | Q9Y6Y8 | |
| AVKGLPEQECEQQQK | 66 | P07476 | |
| LKEAQLPVIENKVCN | 716 | P00747 | |
| LPVLLNKNHDNCDKI | 391 | O00186 | |
| QINCPKDIEAKTLEQ | 566 | Q4LDE5 | |
| AKACKVLRLANNPDI | 236 | Q9UQ84 | |
| PNNCAKIILKTEVDE | 196 | O00463 | |
| LQDNCKKILGENAKP | 306 | Q8N3C0 | |
| LCKNLALDINELKPG | 1286 | A5YKK6 | |
| NEENENCLKKVDPQL | 1101 | Q96JI7 | |
| KELCQGDELCPAEQK | 41 | Q8IUB2 | |
| DPLQNLCEKDLKEIQ | 141 | Q99961 | |
| LCQKEKAELAPVNTE | 606 | Q6NZY4 | |
| KPDLIACLEQNKEPQ | 61 | P0CB33 | |
| LAQLVKECQAPKREL | 31 | Q9H171 | |
| NAIDCLSDEDKKLPQ | 426 | P42285 | |
| GKAKLVILANNCPAL | 41 | P62888 | |
| IVAKSKELDNFCNPI | 771 | O95757 | |
| LCIEQQQLDKPVLDK | 86 | Q8N431 | |
| LGAQVKELEEKCQQP | 216 | Q9C019 | |
| KELEEKCQQPASELL | 221 | Q9C019 | |
| ECNNKLLKENAVPTI | 66 | Q9NVV9 | |
| PLEDLNNKKDSCISN | 1041 | Q99250 | |
| DPALLNCLKQKNTVV | 1571 | Q8IWV7 | |
| QKLCKNDPEGIKDLI | 326 | P53804 | |
| KTPKLDCNIEIQNIA | 316 | Q709C8 | |
| QQKELCGSNKLVAPL | 31 | O60290 | |
| KPDLITCLEQNKESQ | 61 | Q96JC4 | |
| LLALLDKDVPENCKN | 2266 | Q9UPU5 | |
| QELISDPLQQCFKKD | 76 | Q15650 | |
| DPLQQCFKKDEILDG | 81 | Q15650 | |
| LENALCKVKLEEPIN | 791 | O15016 | |
| ENLLCKVNEAAPEKP | 3761 | Q5T4S7 | |
| EVDKVKQDANCVNPL | 1251 | P08575 | |
| SELLPNRQGLKKADC | 2701 | P01266 | |
| LLNQADEVKLQIKCG | 636 | Q7Z4V0 | |
| KDINELNLPKTCDIS | 36 | P61081 | |
| SKRNPEDDGCLLKQE | 346 | Q8N7P7 | |
| DDGCLLKQEPQELRK | 431 | Q8N7P7 | |
| LLPQAEISAICQKKN | 361 | Q9P2D8 | |
| NNLDKNKPDLKDLCS | 471 | Q7Z570 | |
| NKPDLKDLCSQQKQE | 476 | Q7Z570 | |
| KLCQAEAPVQEEKLS | 26 | O76095 | |
| PGNLAVNEDCELKIL | 156 | P53778 |